Form 4: Concentra Executive Granted 60,000 Restricted Shares

John A. deLorimier, Concentra's EVP and Chief Digital & Data Officer, was granted 60,000 restricted common shares vesting over four years.

Summary

• John A. deLorimier, Executive Vice President, Chief Digital & Data Officer of Concentra Group Holdings Parent, Inc., acquired 60,000 shares of common stock.
• The acquisition was a grant of restricted stock, with a transaction date of November 4, 2025.
• These shares will vest in equal annual installments over four years.
• Following this transaction, deLorimier beneficially owns 120,000 shares of common stock directly.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive is a positive step for aligning management incentives with long-term shareholder value and executive retention, reflecting standard corporate governance practices.

Positives

• The grant of 60,000 restricted shares to a key executive, John A. deLorimier, aligns his interests with long-term shareholder value.
• The four-year vesting schedule encourages executive retention and sustained performance within the company.

Future Outlook

The four-year vesting schedule for the restricted stock grant indicates a long-term incentive structure for the executive, aligning future performance with shareholder interests and promoting executive retention.

Management Comments

• The grant of restricted stock to a key executive underscores the company's strategy to incentivize and retain top talent.

Industry Context

Executive stock grants are a common practice in publicly traded companies to align management incentives with long-term shareholder value, particularly in the healthcare services sector where talent retention is crucial for strategic execution and operational stability.

Comparison to Industry Standards

• The use of restricted stock grants with multi-year vesting is a standard compensation practice across various industries, including healthcare, comparable to incentive structures seen at companies like HCA Healthcare or Tenet Healthcare, aiming to foster long-term executive commitment and performance.

Stakeholder Impact

• Shareholders: Potential for increased long-term value alignment with executive interests, fostering stability and strategic execution.
• Employees: May signal confidence in executive leadership and a stable, performance-oriented compensation strategy within the company.

Next Steps

• The restricted shares will vest in equal annual installments over the next four years, implying ongoing performance expectations and a long-term commitment from the executive.

Key Dates

Recommendation

The grant of restricted stock to a key executive is a standard compensation practice that aligns management's long-term interests with those of shareholders. While a positive signal for executive retention and performance incentives, it does not fundamentally alter the company's operational or financial outlook to warrant a change from a 'hold' position based solely on this filing.

Keywords

Concentra, CON, John A. deLorimier, restricted stock, stock grant, executive compensation, insider transaction, Form 4